MorelliT.FujitaK.Redelman-SidiG.ElkingtonPT. Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. Thorax. 2022;77(3):304-311.doi:10.1136/thoraxjnl-2021-21726034607905
2.
MaysAC.YarlagaddaB.AchimVet al. Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer. Head Neck. 2021;43(5):1509-1520.doi:10.1002/hed.2660133417293
3.
EliasAW.KasiPM.StaufferJAet al. The feasibility and safety of surgery in patients receiving immune checkpoint inhibitors: a retrospective study. Front Oncol. 2017;7:121.doi:10.3389/fonc.2017.0012128660171
4.
PuzaCJ.BresslerES.TerandoAMet al. The emerging role of surgery for patients with advanced melanoma treated with immunotherapy. J Surg Res. 2019;236:209-215.doi:10.1016/j.jss.2018.11.04530694757
5.
SunJ.KirichenkoDA.ChungJLet al. Perioperative outcomes of melanoma patients undergoing surgery after receiving immunotherapy or targeted therapy. World J Surg. 2020;44(4):1283-1293.doi:10.1007/s00268-019-05314-231811340